Evidence map›Paper›PMID 28638727›Full record

ArticleOncoimmunology

Identification of an immunogenic neo-epitope encoded by mouse sarcoma using CXCR3 ligand mRNAs as sensors.

Keisuke Fujii, Yoshihiro Miyahara, Naozumi Harada, Daisuke Muraoka, Mitsuhiro Komura, Rui Yamaguchi, Hideo Yagita, Junko Nakamura, Sahoko Sugino, Satoshi Okumura and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Keisuke FujiiDepartment of Immuno-Gene Therapy, Graduate School of Medicine, Mie University, Mie, Japan.
Yoshihiro MiyaharaDepartment of Immuno-Gene Therapy, Graduate School of Medicine, Mie University, Mie, Japan.
Naozumi HaradaDepartment of Immuno-Gene Therapy, Graduate School of Medicine, Mie University, Mie, Japan.
Daisuke MuraokaDepartment of Immuno-Gene Therapy, Graduate School of Medicine, Mie University, Mie, Japan.
Mitsuhiro KomuraLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Rui YamaguchiLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Hideo YagitaDepartment of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
Junko NakamuraDepartment of Immuno-Gene Therapy, Graduate School of Medicine, Mie University, Mie, Japan.
Sahoko SuginoDepartment of Immuno-Gene Therapy, Graduate School of Medicine, Mie University, Mie, Japan.
Satoshi OkumuraDepartment of Immuno-Gene Therapy, Graduate School of Medicine, Mie University, Mie, Japan.
Seiya ImotoDivision of Health Medical Data Science, Health Intelligence Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Satoru MiyanoLaboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Hiroshi ShikuDepartment of Immuno-Gene Therapy, Graduate School of Medicine, Mie University, Mie, Japan.
Mie University · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CXCR3 ligands CXCL9, 10, and 11 play critical roles in the amplification of immune responses by recruiting CXCR3

Indexed as

Checkpoint blockadeCXCR3 ligandsimmune responsemutated antigenneo-epitope

Identifiers

PMID28638727
PMCPMC5467990
OpenAlexW2603145748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.